Literature DB >> 21248321

Towards individualised treatment in COPD.

James Fingleton, Mark Weatherall, Richard Beasley.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21248321     DOI： 10.1136/thx.2010.155564

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  8 in total

Review 1.  The asthma COPD overlap syndrome (ACOS).

Authors:  Stephen Bujarski; Amit D Parulekar; Amir Sharafkhaneh; Nicola A Hanania
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

2.  Development and validation of a multivariable mortality risk prediction model for COPD in primary care.

Authors:  Syed A Shah; Bright I Nwaru; Aziz Sheikh; Colin R Simpson; Daniel Kotz
Journal:  NPJ Prim Care Respir Med       Date:  2022-05-31       Impact factor: 3.289

3.  Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality.

Authors:  Pierre-Régis Burgel; Jean-Louis Paillasseur; Bernard Peene; Daniel Dusser; Nicolas Roche; Johan Coolen; Thierry Troosters; Marc Decramer; Wim Janssens
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

4.  Integral Health Status-Based Cluster Analysis in Moderate-Severe COPD Patients Identifies Three Clinical Phenotypes: Relevant for Treatment As Usual and Pulmonary Rehabilitation.

Authors:  Jeannette B Peters; Lonneke M Boer; Johan Molema; Yvonne F Heijdra; Judith B Prins; Jan H Vercoulen
Journal:  Int J Behav Med       Date:  2017-08

5.  Multi-scale computational models of the airways to unravel the pathophysiological mechanisms in asthma and chronic obstructive pulmonary disease (AirPROM).

Authors:  K S Burrowes; J De Backer; R Smallwood; P J Sterk; I Gut; R Wirix-Speetjens; S Siddiqui; J Owers-Bradley; J Wild; D Maier; C Brightling
Journal:  Interface Focus       Date:  2013-04-06       Impact factor: 3.906

6.  Chronic obstructive pulmonary disease lost in translation: Why are the inhaled corticosteroids skeptics refusing to go?

Authors:  Faisal A Ai-Kassimi; Esam H Alhamad
Journal:  Ann Thorac Med       Date:  2013-01       Impact factor: 2.219

7.  Abrupt withdrawal of inhaled corticosteroids does not result in spirometric deterioration in chronic obstructive pulmonary disease: Effect of phenotyping?

Authors:  Feisal A Al-Kassimi; Esam H Alhamad; Mohammed S Al-Hajjaj; Abdullah A Abba; Emad Raddaoui; Shaffi A Shaikh
Journal:  Ann Thorac Med       Date:  2012-10       Impact factor: 2.219

8.  Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation.

Authors:  Jill A Ohar; Glenn D Crater; Amanda Emmett; Thomas J Ferro; Andrea N Morris; Ibrahim Raphiou; Peruvemba S Sriram; Mark T Dransfield
Journal:  Respir Res       Date:  2014-09-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.